论文信息 - Efficacy and safety of pioglitazone in a phase 1/2 imatinib discontinuation trial (EDI‐PIO) in chronic myeloid leukemia with deep molecular response - 字舞流文

Efficacy and safety of pioglitazone in a phase 1/2 imatinib discontinuation trial (EDI‐PIO) in chronic myeloid leukemia with deep molecular response

E. V. de Paula | C. D. de Souza | M. Delamain | E. Miranda | G. Duarte | K. Pagnano | Valquiria Povoa | A. B. P. Lopes | B. S. Rodrigues | G. C. P. Furlin | J. Vianna | M. S. Da Silva | E. D. de Paula | K. B. Pagnano | G. P. Furlin